Dr Paul Brooker is Chair of the ABPI Nonclinical and Biological Discovery Expert Network (NaBDEN) and is President Europe, Middle East & Asia Pacific (EMEA) and President CRS at Envigo.Read more
The Association of the British Pharmaceuticals Industry (ABPI) has responded to the International Comparisons of Health Technology Assessment report, published today, and also addressed claims that patients are being denied life-prolonging treatments for cancer.Read more
Following today’s High Court ruling by Mr Justice Green on the commissioning of Pre-Exposure Prophylaxis (PrEP) and the subsequent appeal of this ruling by NHS England, the Association of the British Pharmaceutical Industry (ABPI) has responded calling for a commissioning process that is fair, consistent and transparent.Read more
The Association of the British Pharmaceutical Industry (ABPI) has responded to the outcome of the Stern Review into the Research Excellence Framework (REF), published on Thursday 28 July.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.